Historically Black Cheyney University has entered into a partnership with Navrogen Inc. Under the agreement, the research unit of the biopharmaceutical firm will relocate its operations to Cheyney’s Science Center.
Navrogen is involved in cancer research. The firm focuses its research in the area of humoral immuno oncology, a process whereby tumors produce factors that suppress the beneficial effects of a patient’s immune systems against cancer as well as the therapeutic effects of antibody-based anti-cancer therapies.
The partnership will provide financial assistance to the university and provide Cheyney students with research opportunities and internships.
Aaron Walton, president of Cheyney University, stated that “this arrangement will produce a major benefit to the university and our students, who will have an opportunity to work on these cancer-fighting projects and get hands-on experience in biomolecular techniques as either interns or mentees.”
